Signet Therapeutics Company
Signet Therapeutics is a biopharmaceutical startup focusing on developing innovative targeted cancer drugs using novel disease models.
Industry:
Early and Preclinical Drug Development
Last Funding Type:
Seed
Funding Status:
Seed
Total Funding:
20000000
Investors Number:
5
Headquarters:
Newton, Massachusetts, United States
Last Funding Date:
2021-10-29
Founded Date:
2020-01-01